Phathom Pharmaceuticals (PHAT) Capital Expenditures (2019 - 2025)
Phathom Pharmaceuticals (PHAT) reported Capital Expenditures of $178000.0 for Q4 2025, up 3460.0% year-over-year from $5000.0 in Q4 2024, and up 378.12% quarter-over-quarter from -$64000.0 in Q3 2025.
Phathom Pharmaceuticals (PHAT) Capital Expenditures (2019 - 2025) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 7 years of Capital Expenditures data on file, last reported at $178000.0 in Q4 2025.
- Capital Expenditures for Q4 2025 came in at $178000.0, up 3460.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $211000.0 (up 44.52% YoY), and the FY2025 annual result was $229000.0, up 69.63% from the prior year.
- Capital Expenditures advanced to $178000.0 in Q4 2025 per PHAT's latest filing, from -$64000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $939000.0 in Q3 2023 and troughed at -$1.1 million in Q4 2023.
- A 5-year average of $42400.0 and a median of $19500.0 in 2021 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2021 and 2025: Capital Expenditures sank 1178.95% in 2021, then surged 3460.0% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $319000.0 in 2021, then plunged by 253.92% to -$491000.0 in 2022, then tumbled by 132.38% to -$1.1 million in 2023, then soared by 100.44% to $5000.0 in 2024, then surged by 3460.0% to $178000.0 in 2025.
- Business Quant data shows PHAT's Capital Expenditures at $178000.0 in Q4 2025, -$64000.0 in Q3 2025, and $97000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Phathom Pharmaceuticals | 895.99 Mn | 712.23 Mn | 46.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 178,000.00 |
| Dec 31, 2025 | 178,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Jun 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 97,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | -1.14 Mn |
| Dec 31, 2023 | -1.14 Mn |
| Sep 30, 2023 | 939,000.00 |
| Sep 30, 2023 | 939,000.00 |